The effects of triethanolamine myristate, a fatty acid salt, on the availability of riboflavin in humans

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue 1, 1997, Pages 73-76

  Forusz, H ^a   Ritschel, W A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

delayed gastric emptying; riboflavin; triethanolamine myristate

Indexed keywords

FATTY ACID DERIVATIVE; RIBOFLAVIN; TRIETHANOLAMINE MYRISTATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; ORAL DRUG ADMINISTRATION; STOMACH EMPTYING; SUSTAINED RELEASE FORMULATION; TABLET;

ADULT; DRUG DELIVERY SYSTEMS; DRUG INTERACTIONS; ETHANOLAMINES; GASTRIC EMPTYING; HUMANS; MALE; MYRISTIC ACID; MYRISTIC ACIDS; RIBOFLAVIN;

EID: 0030907402     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Ritschel, W.A. RESID: A curve-fitting program to generate pharmacokinetic parameters. Int Symp Clin Pharmacokinet (July 20-21, city?) 1975.
2. Ritschel, W.A. Cumulative urinary excretion. In: Handbook of Basic Pharmacokinetics. Drug Intelligence Publications, Inc.: Hamilton, IL 1986, 252-68.